Virginia program found to cut average billed dose per week by 40% compared with the national average. ORLANDO—Patients receiving nocturnal hemodialysis may have lower erythropoietin (EPO) requirements ...
PHILADELPHIA—Epoetin alfa (EPO) use has decreased and intravenous (IV) iron use has increased significantly in private dialysis units since the introduction of the Medicare bundling rule for end-stage ...
SAN FRANCISCO (MarketWatch) -- Amgen Inc. Friday said an administrative law judge at the U.S. International Trade Commission in Washington has determined that Roche's importation and use of peg-EPO in ...
WASHINGTON (Reuters) - The U.S. Medicare health insurance program proposed limiting payments for Amgen Inc. and Johnson & Johnson anemia drugs on Monday in response to safety concerns. Sign up here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results